Overview

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

Status:
Recruiting
Trial end date:
2024-08-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of SHR0302 ointment in adult patients with Vitiligo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Reistone Biopharma Company Limited